Technical Analysis for ADMA - ADMA Biologics Inc

Grade Last Price % Change Price Change
grade D 3.04 4.83% 0.14
ADMA closed up 4.83 percent on Monday, August 10, 2020, on 1.48 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical ADMA trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 4.83%
Calm After Storm Range Contraction 4.83%
Narrow Range Bar Range Contraction 4.83%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Medicine Biotechnology Health Biopharmaceutical Biology Pharmaceutical Industry Immunology Infectious Diseases Antibodies Immune System Antibody Glycoproteins Late Stage Biopharmaceutical

Is ADMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.4844
52 Week Low 1.45
Average Volume 4,300,632
200-Day Moving Average 3.43
50-Day Moving Average 3.01
20-Day Moving Average 3.11
10-Day Moving Average 3.20
Average True Range 0.31
ADX 21.56
+DI 31.11
-DI 21.17
Chandelier Exit (Long, 3 ATRs ) 3.28
Chandelier Exit (Short, 3 ATRs ) 3.63
Upper Bollinger Band 3.67
Lower Bollinger Band 2.56
Percent B (%b) 0.43
BandWidth 35.65
MACD Line 0.05
MACD Signal Line 0.07
MACD Histogram -0.0235
Fundamentals Value
Market Cap 78.41 Million
Num Shares 25.8 Million
EPS -1.77
Price-to-Earnings (P/E) Ratio -1.72
Price-to-Sales 5.85
Price-to-Book 2.60
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.51
Resistance 3 (R3) 3.47 3.29 3.43
Resistance 2 (R2) 3.29 3.17 3.30 3.40
Resistance 1 (R1) 3.16 3.10 3.23 3.20 3.38
Pivot Point 2.98 2.98 3.01 2.99 2.98
Support 1 (S1) 2.85 2.86 2.92 2.89 2.70
Support 2 (S2) 2.67 2.79 2.68 2.68
Support 3 (S3) 2.54 2.67 2.65
Support 4 (S4) 2.58